Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization

Coronary Artery Disease(CAD) Clinical Trial

Official title: Study of Curative Effect Evaluation of DanLou Tablet on Coronary Artery Disease Not Amenable to Revascularization on the Basis of Western Medicine Therapy

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to determine whether Danlou Tablet is effective in the treatment of coronary artery disease not amenable to revascularization on the basis of western medicine therapy.

Clinical Trial Description

The western medicine treatment for CAD not amenable to revascularization is limited. Danlou Tablet, a kind of Chinese patent medicine has been used for treating coronary artery disease in clinical practice in China for many years.

Danlou Tablet is applicable to "phlegm-stasis syndrome" in Traditional Chinese Medicine. According to recent studies, Danlou Tablet can reduce blood lipid level and myocardial necrosis area ,promote infarct healing in rats.And it can improve clinical symptoms of patients with CAD. ;

Related Conditions & MeSH terms

• Coronary Artery Disease
• Coronary Artery Disease(CAD)
• Coronary Disease
• Myocardial Ischemia

• NCT number: NCT03072082
• Study type: Interventional
• Source: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
• Contact: Jun Li, MD
• Phone: +86 13051458913
• Email: 13051458913@163.com
• Status: Not yet recruiting
• Phase: Phase 4
• Start date: June 2017
• Completion date: February 2019